and Sinovac
Rich countries corner nearly 51% supply of five major COVID-19 vaccine candidates: Oxfam
According to a recent study by Oxfam International, wealthy nations, which account for nearly 13% of the global population, have cornered a lion’s share of supply deals for vaccine candidates in phase-3 of the clinical trials
- Edmundo González has left Venezuela.
- 300,000 march against Macron’s appointment of conservative prime minister
- Right-wing fear mongering over gangs in Colorado obscures larger issue of landlord neglect
- Macron faces protest over appointment of right-wing PM
- Cry of the Excluded marks 30 years defending “true independence” in Brazil
